elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28548630-2A9FD0B4-F552-411F-8292-6F00688F6B3E
Q28548630-2A9FD0B4-F552-411F-8292-6F00688F6B3E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28548630-2A9FD0B4-F552-411F-8292-6F00688F6B3E
Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia
P2860
Q28548630-2A9FD0B4-F552-411F-8292-6F00688F6B3E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28548630-2A9FD0B4-F552-411F-8292-6F00688F6B3E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bfc377ee1142861ac8aa10a82df032180376159a
P2860
Class-sparing regimens for initial treatment of HIV-1 infection.